Financial News

Financial Report: Merck

Pharmaceutical sales up 2% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Merck 2Q Revenues: $9.8 billion (+1%) 2Q Earnings: $1.2 billion (+100%) YTD Revenues: $19.2 billion (flat) YTD Earnings: $2.3 billion (+42%) Comments: Pharmaceutical sales were up 2% to $8.7 billion, with higher sales in oncology, hospital acute care, the cardiovascular franchise and vaccines. KEYTRUDA sales were $314 million in the quarter, up from $110 million 2Q15. CUBICIN sales were $357 million, up 22%. The company launched HCV drug ZEPATIER, which had sales of $112 million i...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters